Ali Behbahani Insider Trading $MRKR Marker Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ali Behbahani.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ali Behbahani. Ali Behbahani is 10% Owner in Marker Therapeutics, Inc. ($MRKR) and Director in NEVRO CORP ($NVRO) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and Director in Nkarta, Inc. ($NKTX).

Ali Behbahani in Marker Therapeutics, Inc.

Trading Symbol: MRKR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 10,714,285 shares
Current Value: $47,678,568
Latest Transaction: Mar 18 2021
$MRKR Market Capitalization: $36.11M
$MRKR Previous Close: $4.45

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Ali Behbahani in Marker Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADAP, AKUS, BDTX, CRSP, GNCA, MRKR, MTCR, MIRM, NVRO, NKTX, OYST, RGLS, TRVI

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 18 2021	MRKR	Marker Therapeutic ...	Behbahani Ali	10% Owner	Buy	P	1.75	5,714,285	9,999,999	10,714,285	5 M to 10.7 M (+114.29 %)

Page: 1